These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27994513)

  • 1. LIS1 Regulates Osteoclastogenesis through Modulation of M-SCF and RANKL Signaling Pathways and CDC42.
    Ye S; Fujiwara T; Zhou J; Varughese KI; Zhao H
    Int J Biol Sci; 2016; 12(12):1488-1499. PubMed ID: 27994513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cytoplasmic Dynein Associated Protein NDE1 Regulates Osteoclastogenesis by Modulating M-CSF and RANKL Signaling Pathways.
    Das BK; Gogoi J; Kannan A; Gao L; Xing W; Mohan S; Zhao H
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1.
    Ye S; Fowler TW; Pavlos NJ; Ng PY; Liang K; Feng Y; Zheng M; Kurten R; Manolagas SC; Zhao H
    PLoS One; 2011; 6(11):e27285. PubMed ID: 22073305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis.
    Leung R; Wang Y; Cuddy K; Sun C; Magalhaes J; Grynpas M; Glogauer M
    J Bone Miner Res; 2010 May; 25(5):1077-91. PubMed ID: 19929439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone.
    De Vries TJ; Schoenmaker T; Aerts D; Grevers LC; Souza PP; Nazmi K; van de Wiel M; Ylstra B; Lent PL; Leenen PJ; Everts V
    J Cell Physiol; 2015 Jan; 230(1):210-25. PubMed ID: 24962140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
    BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
    PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class A Scavenger Receptor Exacerbates Osteoclastogenesis by an Interleukin-6-Mediated Mechanism through ERK and JNK Signaling Pathways.
    Guo S; Ni Y; Ben J; Xia Y; Zhou T; Wang D; Ni J; Bai H; Wang L; Ma J; Chen Q
    Int J Biol Sci; 2016; 12(10):1155-1167. PubMed ID: 27766031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.
    Lamothe B; Lai Y; Xie M; Schneider MD; Darnay BG
    Mol Cell Biol; 2013 Feb; 33(3):582-95. PubMed ID: 23166301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.
    Duplomb L; Baud'huin M; Charrier C; Berreur M; Trichet V; Blanchard F; Heymann D
    Endocrinology; 2008 Jul; 149(7):3688-97. PubMed ID: 18403479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis.
    Wang Y; Lebowitz D; Sun C; Thang H; Grynpas MD; Glogauer M
    J Bone Miner Res; 2008 Feb; 23(2):260-70. PubMed ID: 17922611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption.
    Luo J; Yang Z; Ma Y; Yue Z; Lin H; Qu G; Huang J; Dai W; Li C; Zheng C; Xu L; Chen H; Wang J; Li D; Siwko S; Penninger JM; Ning G; Xiao J; Liu M
    Nat Med; 2016 May; 22(5):539-46. PubMed ID: 27064449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling.
    Strålberg F; Henning P; Gjertsson I; Kindlund B; Souza PP; Persson E; Abrahamson M; Kasprzykowski F; Grubb A; Lerner UH
    FASEB J; 2013 Jul; 27(7):2687-701. PubMed ID: 23572233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory M1 Macrophages Inhibit RANKL-Induced Osteoclastogenesis.
    Yamaguchi T; Movila A; Kataoka S; Wisitrasameewong W; Ruiz Torruella M; Murakoshi M; Murakami S; Kawai T
    Infect Immun; 2016 Oct; 84(10):2802-12. PubMed ID: 27456834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembled RANK induces osteoclastogenesis ligand-independently.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 Nov; 20(11):2053-60. PubMed ID: 16234979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.